| Inhibition of cholesterol biosynthesis overcomes enzalutamide resistance in castration-resistant prostate cancer (CRPC) Y Kong, L Cheng, F Mao, Z Zhang, Y Zhang, E Farah, J Bosler, Y Bai, ... Journal of Biological Chemistry 293 (37), 14328-14341, 2018 | 103 | 2018 |
| Fndc5 loss‐of‐function attenuates exercise‐induced browning of white adipose tissue in mice Y Xiong, Z Wu, B Zhang, C Wang, F Mao, X Liu, K Hu, X Sun, W Jin, ... The FASEB Journal 33 (5), 5876-5886, 2019 | 59 | 2019 |
| Plk1 inhibition enhances the efficacy of BET epigenetic reader blockade in castration-resistant prostate cancer F Mao, J Li, Q Luo, R Wang, Y Kong, C Carlock, Z Liu, BD Elzey, X Liu Molecular cancer therapeutics 17 (7), 1554-1565, 2018 | 44 | 2018 |
| Inhibition of EZH2 enhances the antitumor efficacy of metformin in prostate cancer Y Kong, Y Zhang, F Mao, Z Zhang, Z Li, R Wang, J Liu, X Liu Molecular cancer therapeutics 19 (12), 2490-2501, 2020 | 23 | 2020 |
| Epigenetics in prostate cancer treatment K Jones, Y Zhang, Y Kong, E Farah, R Wang, C Li, X Wang, ZZ Zhang, ... Journal of translational genetics and genomics 5, 341, 2021 | 14 | 2021 |
| The kinase PLK1 promotes the development of Kras/Tp53-mutant lung adenocarcinoma through transcriptional activation of the receptor RET Y Kong, DB Allison, Q Zhang, D He, Y Li, F Mao, C Li, Z Li, Y Zhang, ... Science signaling 15 (754), eabj4009, 2022 | 13 | 2022 |
| Inhibition of the erythropoietin-producing receptor EPHB4 antagonizes androgen receptor overexpression and reduces enzalutamide resistance C Li, NA Lanman, Y Kong, D He, F Mao, E Farah, Y Zhang, J Liu, C Wang, ... Journal of Biological Chemistry 295 (16), 5470-5483, 2020 | 13 | 2020 |
| Phosphorylation of AHR by PLK1 promotes metastasis of LUAD via DIO2-TH signaling C Li, DB Allison, D He, F Mao, X Wang, P Rychahou, IA Imam, Y Kong, ... PLoS Genetics 19 (11), e1011017, 2023 | 4 | 2023 |
| GSTM2 is a key molecular determinant of resistance to SG-ARIs C Li, J Liu, D He, F Mao, X Rao, Y Zhao, NA Lanman, M Kazemian, ... Oncogene 41 (40), 4498-4511, 2022 | 4 | 2022 |
| Diptoindonesin G antagonizes AR signaling and enhances the efficacy of antiandrogen therapy in prostate cancer F Mao, Y Kong, J Liu, X Rao, C Li, K Donahue, Y Zhang, K Jones, ... The Prostate 82 (8), 917-932, 2022 | 4 | 2022 |
| Single-cell analysis identifies PLK1 as a driver of immunosuppressive tumor microenvironment in LUAD Y Kong, C Li, J Liu, S Wu, M Zhang, DB Allison, F Hassan, D He, X Wang, ... PLoS genetics 20 (6), e1011309, 2024 | 2 | 2024 |
| Elevating PLK1 overcomes BETi resistance in prostate cancer via triggering BRD4 phosphorylation-dependent degradation in mitosis Y Zhang, KW Fong, F Mao, R Wang, DB Allison, D Napier, D He, J Liu, ... Cell reports 43 (7), 2024 | 1 | 2024 |
| Plk1 phosphorylation of PHGDH to regulate serine metabolism X Rao, DB Allison, RM Flight, Y Wu, T Scott, D He, RX Wang, Z Li, C Li, ... Cancer Research 83 (7_Supplement), 3673-3673, 2023 | 1 | 2023 |
| Plk1 attenuates colon inflammation and tumorigenesis X Wang, D he, F Mao, Y Kong, C Li, S Wu, J Peng, C Wang, Z Li, X Liu Cancer Research 84 (6_Supplement), 1406-1406, 2024 | | 2024 |
| Dysregulation of mitochondrial function by PLK1-mediated PDHA1 phosphorylation promotes Cr (VI)-associated lung cancer progression Q Zhang, Z Li, X Rao, DB Allison, Q Qiao, ZZ Zhang, Y Kong, Y Zhang, ... bioRxiv, 2024.02. 16.580630, 2024 | | 2024 |
| Single-cell analysis characterizes PLK1 as a catalyst of an immunosuppressive tumor microenvironment in LUAD Y Kong, C Li, J Liu, M Zhang, DB Allison, F Hassan, D He, X Wang, F Mao, ... bioRxiv, 2023.08. 02.551692, 2023 | | 2023 |
| Single-cell analysis characterizes PLK1 as a promoter of immunosuppressive tumor microenvironment in LUAD Y Kong, C Li, J Liu, M Zhang, DB Allison, F Hassan, D He, X Wang, F Mao, ... | | 2023 |
| Phosphorylation of AHR by PLK1 promotes metastasis of LUAD via upregulation of DIO2 C Li, D He, F Mao, X Wang, Y Hao, Y Kong, CF Brainson, J Liu, Y Zhang, ... Cancer Research 83 (7_Supplement), 2578-2578, 2023 | | 2023 |
| Taxol-elevated PLK1 overcomes BETi-resistant in prostate cancer via triggering phosphorylation-dependent degradation of BRD4 Y Zhang, KW Fong, F Mao, R Wang, Y Kong, C Li, J Liu, Z Li, DB Allison, ... Cancer Research 83 (7_Supplement), 4992-4992, 2023 | | 2023 |
| PLK1 promotes the metastasis and drug resistance in melanoma F Mao, Y Kong, C Li, Y Zhang, X Rao, Q Zhang, X Wang, Z Li, X Liu Cancer Research 83 (7_Supplement), 4997-4997, 2023 | | 2023 |
